DC Funds, LP
An institutional investment manager in MCLEAN, VA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1869028.
- Reported value$1.3m
- Positions3
Holdings: 3 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$k | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Tscan Therapeutics IncTCRX | COM | 89854M101 | 617 | 49.3% | 630,000 | Unchanged | |
| Barinthus Biotherapeutics PL | ADS | 91864C107 | 424 | 33.8% | 642,204 | Unchanged | |
| Werewolf Therapeutics IncHOWL | COM | 95075A107 | 212 | 16.9% | 589,102 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001398344-26-014487 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.